• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Cantor Fitzgerald initiated coverage on Aspira Womens Health with a new price target

    1/29/21 6:12:39 AM ET
    $AWH
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Get the next $AWH alert in real time by email
    Cantor Fitzgerald initiated coverage of Aspira Womens Health with a rating of Overweight and set a new price target of $10.00
    Get the next $AWH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AWH

    DatePrice TargetRatingAnalyst
    1/12/2022$4.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $AWH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Schuler Jack W bought 6,536 shares (SEC Form 4)

      4 - Aspira Women's Health Inc. (0000926617) (Issuer)

      7/11/24 5:15:45 PM ET
      $AWH
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • Large owner Schuler Jack W bought 28,500 shares (SEC Form 4)

      4 - Aspira Women's Health Inc. (0000926617) (Issuer)

      6/18/24 4:12:21 PM ET
      $AWH
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • Sandford Nicole bought $22,973 worth of shares (9,493 units at $2.42), increasing direct ownership by 16% to 70,596 units (SEC Form 4)

      4 - Aspira Women's Health Inc. (0000926617) (Issuer)

      6/3/24 5:30:57 PM ET
      $AWH
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care

    $AWH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cantor Fitzgerald resumed coverage on Aspira Women's Health with a new price target

      Cantor Fitzgerald resumed coverage of Aspira Women's Health with a rating of Overweight and set a new price target of $4.00

      1/12/22 7:53:25 AM ET
      $AWH
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • Truist Securities initiated coverage on Aspira Womens Health with a new price target

      Truist Securities initiated coverage of Aspira Womens Health with a rating of Buy and set a new price target of $12.00

      3/29/21 7:32:28 AM ET
      $AWH
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • Cantor Fitzgerald initiated coverage on Aspira Womens Health with a new price target

      Cantor Fitzgerald initiated coverage of Aspira Womens Health with a rating of Overweight and set a new price target of $10.00

      1/29/21 6:12:39 AM ET
      $AWH
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care

    $AWH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Fraser John D claimed ownership of 841,558 shares (SEC Form 3)

      3 - Aspira Women's Health Inc. (0000926617) (Issuer)

      4/28/25 7:19:40 PM ET
      $AWH
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form 3 filed by new insider Hundorfean Cynthia D

      3 - Aspira Women's Health Inc. (0000926617) (Issuer)

      4/24/25 9:41:23 PM ET
      $AWH
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • Director Vos Ellen O'Connor converted options into 5,313 shares, increasing direct ownership by 8% to 68,677 units (SEC Form 4)

      4 - Aspira Women's Health Inc. (0000926617) (Issuer)

      4/2/25 8:23:47 AM ET
      $AWH
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care